update
US FDA issues Dr Reddy's with Form 483 for UK plant
![Dr Reddy's API site (source Google maps)](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_large/0/7/8/9/7359870-1-eng-GB/US-FDA-issues-Dr-Reddy-s-with-Form-483-for-UK-plant.jpg)
The US Food and Drug Administration (FDA) has found problems at a Dr Reddy’s API plant in the UK.
The Indian drug firm announced the inspection in a Bombay Stock Exchange (BSE) filing on Friday, explaining that agency inspectors who visited its facility in Mirfield, Yorkshire issued it with a Form 483 detailing three observations.
Dr Reddy's declined to provide details of the obervations, but did confirm that the plant will continue to supply the US, UK and European markets.